| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.9 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.9 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |